Glycoprotein isolated from Solarium nigrum L. modulates the apoptotic-related signals in 12-O-tetradecanoylphorbol 13-acetate-stimulated MCF-7 cells

Journal of Medicinal Food

Volumn 8, Issue 1, 2005, Pages 69-77

  Heo, Kyung Sun ^a   Lim, Kye Taek ^a  

^a Chonnam National University   (South Korea)

Author keywords

12 O tetradecanoylphorbol 13 acetate; Apoptosis; Glycoprotein of Solanum nigrum L.; Nuclear factor B; Protein kinase C ; SNL glycoprotein

Indexed keywords

ANTINEOPLASTIC AGENT; DNA FRAGMENT; ETHIDIUM BROMIDE; GLYCOPROTEIN; HOE 33342; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PHORBOL 13 ACETATE 12 MYRISTATE; PLANT EXTRACT; PROTEIN KINASE C ALPHA; PYRROLIDINE DITHIOCARBAMATE; SOLANUM NIGRUM EXTRACT; STAUROSPORINE; UNCLASSIFIED DRUG; ENZYME INHIBITOR; PRKCA PROTEIN, HUMAN; PROTEIN KINASE C; PYRROLIDINE; PYRROLIDINE DERIVATIVE; VEGETABLE PROTEIN;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BREAST CANCER; CELL NUCLEUS; CELL STRAIN MCF 7; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN TRANSPORT; SOLANUM NIGRUM; TUMOR PROMOTION; WESTERN BLOTTING; CHEMISTRY; DRUG ANTAGONISM; DRUG EFFECT; ISOLATION AND PURIFICATION; METABOLISM; PHYSIOLOGY; TUMOR CELL LINE;

MINK CELL FOCUS-FORMING VIRUS; SOLANUM NIGRUM; SOLARIUM;

ANTINEOPLASTIC AGENTS; APOPTOSIS; BLOTTING, WESTERN; CELL LINE, TUMOR; DNA FRAGMENTATION; ENZYME INHIBITORS; GLYCOPROTEINS; HUMANS; NF-KAPPA B; PLANT PROTEINS; PROTEIN KINASE C; PROTEIN KINASE C-ALPHA; PYRROLIDINES; SOLANUM NIGRUM; STAUROSPORINE; TETRADECANOYLPHORBOL ACETATE;

EID: 18144377378     PISSN: 1096620X     EISSN: None     Source Type: Journal    
DOI: 10.1089/jmf.2005.8.69     Document Type: Article

References (41)

1. Prashanth Kumar V, Shashidhara S, Kumar MM, Sridhara BY: Cytoprotective of Solatium nigrum against gentamicin-induced kidney cell (Vero cells) damage in vitro. Fitoterapia 2001;72:481-486.
2. Sultana S, Perwaiz S, Iqbal M, Athar M: Crude extracts of hepatoprotective plants, Solatium nigrum and Cichorium intybus inhibit free radical-mediated DNA damage. J Ethnopharmacol 1995;45:189-192.
3. Saijo R, Murakami K, Nohara T, Tomimatsu T, Sato A, Matsuoka K: Studies on the constituents of Solanum plants. II. On the constituents of the immature berries of Solatium nigrum L. (author's transl). Yakugaku Zasshi 1982;102:300-305.
4. Ikeda T, Tsumagari H, Nobara T: Steroidal oligoglycosides from Solatium nigrum. Chem Pharm Bull (Tokyo) 2000;48:1062-1064.
5. Lee SJ, Lim KT: Antioxidative effects of glycoprotein isolated from Solatium nigrum Linne on oxygen radicals and its cytotoxic effects on the MCF-7 cell. J Food Sci 2003;68:466-470.
6. Lim KT, Heo KS, Son YO: Antioxidative and antimicrobial effects of glycoprotein isolated from Solatium nigrum Linne. Food Sci Biotechnol 2002;5:484-489.
7. Barry OP, Kazanietz MG: Protein kinase C isozymes, novel phorbol ester receptors and cancer chemotherapy. Curr Pharm Des 2001;7:1725-1744.
8. Isonishi S, Ohkawa K, Tanaka T, Howell SB: Depletion of protein kinase C (PKC) by 12-O-tetradecanoylphorbol-13-acetate (TPA) enhances platinum drug sensitivity in human ovarian carcinoma cells. Br J Cancer 2000;82:34-38.
9. Mullin JM, Laughlin KV, Ginanni N, Marano CW, Clarke HM, Peralta Soler A: Increased tight junction permeability can result from protein kinase C activation/translocation and act as a tumor promotional event in epithelial cancers. Ann N Y Acad Sci 2000;915:231-236.
10. McConkey DJ, Greene G, Pettaway CA: Apoptosis resistance increases with metastatic potential in cells of the human LNCaP prostate carcinoma line. Cancer Res 1996;56:5594-5599.
11. Shi X, Ye J, Leonard SS, Ding M, Vallyathan V, Castranova V, Rojanasakul Y, Dong Z: Antioxidant properties of (-)-epicatechin-3-gallate and its inhibition of Cr(VI)-induced DNA damage and Cr(IV)- or TPA-stimulated NF-kappaB activation. Mol Cell Biochem 2000;206:125-132.
12. Deacon EM, Pongracz J, Griffiths G, Lord JM: Isoenzymes of protein kinase C: Differential involvement in apoptosis and pathogenesis. Mol Pathol 1997;50:124-131.
13. Johnson MD, Torri JA, Lippman ME, Dickson RB: Regulation of motility and protease expression in PKC-mediated induction of MCF-7 breast cancer cell invasiveness. Exp Cell Res 1999;247:105-113.
14. Morse-Gaudio M, Connolly JM, Rose DP: Protein kinase C and its isoforms in human breast cancer cells: Relationship to the invasive phenotype. Int J Oncol 1998;12:1349-1354.
15. Boyan BD, Sylvia VL, Frambach T, Lohmann CH, Dietl J, Dean DD, Schwartz Z: Estrogen-dependent rapid activation of protein kinase C in estrogen receptor-positive MCF-7 breast cancer cells and estrogen receptor-negative HCC38 cells is membrane-mediated and inhibited by tamoxifen. Endocrinology 2003;44:1812-1824.
16. de Martin R, Schmid JA, Hofer-Warbinek R: The NF-kappaB/Rel family of transcription factors in oncogenic transformation and apoptosis. Mutat Res 1999;437:231-243.
17. Baldwin A: The NF-κB and IκB protein: New discoveries and in sights. Annu Rev Immunol 1996;14:649-683.
18. Wu M, Lee H, Bellas RE, Schauer SL, Arsura M, Katz D, Fizgerald MJ, Rothstein TL, Sherr DH, Sonenshein GE: Inhibition of NF-κB/Rel induces apoptosis of murine B cells. EMBO J 1996;15:4682-4690.
19. Mukhopadhyay A, Bueso-Ramos C, Chatterjee D, Pantazis P, Aggarwal BB: Curcumin downregulates cell survival mechanisms in human prostate cancer cell lines. Onmgene 2001;20:7597-7609.
20. Horwitz AR, Parsons JT: Cell migration-movin' on. Science 1999;286:1102-1103.
21. Kerr JF, Wyllie AH, Currie AR: Apoptosis: A basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 1972;26:239-257.
22. Barkett M, Gilmore TD: Control of apoptosis by Rel/NF-kappaB transcription factors. Oncogens 1999;18:6910-6924.
23. Liu X, Pisha E, Tonetti DA, Yao D, Li Y, Yao J, Burdette JE, Bolton JL: Antiestrogenic and DNA damaging effects induced by tamoxifen and toremifene metabolites. Chem Res Toxicol 2003;16:832-837.
24. Surh Y-J: Cancer chemoprevention with dietary phytochemicals. Nat Rev Cancer 2003;3:768-780.
25. Naik PN, Karrim J, Hanahan D: The rise and fall of apoptosis during multistage tumorigenesis: Down-modulation contributes to tumor progression from angiogenic progenitors. Gene Dev 1996;10:2105-2116.
26. Thompson CB: Apoptosis in the pathogenesis and treatment of disease. Science 1995;267:1456-1462.
27. Wu GS, El-Deiry WS: Apoptotic death of tumor cells correlates with chemosensitivity, independent of p53 or bcl-2. Clin Cancer Res 1996;2:623-633.
28. Chakrabarty S, Huang S: Modulation of chemosensitivity in human colon carcinoma cells hy downregulating protein kinase C alpha expression. J Exp Ther Oncol 1996;1:218-221.
29. Jaken S: Protein kinase C isozymes and substrates. Curr Opin Cell Biol 1996;8:168-173.
30. Chakrabarty S, Reynolds S, Wang HM, Rajagopal S: Action of polypeptide growth factors in colon cancer; development of new therapeutic approaches. Front Biosci 1997;2:d460-d470.
31. Karin M: How NF-kappa B is activated: the role of the Ikappa B kinase (IKK) complex. Oncogene 1999;18:6867-6874.
32. Scaife CL, Kuang J, Wills JC, Trowbridge DB, Gray P, Manning BM, Eichwald EJ, Daynes RA, Kuwada SK: Nuclear factor kappaB inhibitors induce adhesion-dependent colon cancer apoptosis: Implications for metastasis. Cancer Res 2002;62:6870-6878.
33. Bargou RC, Emmerich F, Krappmann D, Bommert K, Mapara MY, Arnold W, Royer HD, Grinstein E, Greiner A, Scheidereit C, Dorken B: Constitutive nuclear factor-kappaB-RelA activation is required for proliferation and survival of Hodgkin's disease tumor cells. J Clin Invest 1997;100:2961-2969.
34. Barinaga M: Life-death balance within the cell. Science 1996;274:724.
35. Giri DK, Aggarwal BB: Constitutive activation of NF-kappa B causes resistance to apoptosis in human cutaneous T cell lymphoma HuT-78 cells. J Biol Chem 1998;273:14008-14014.
36. Sarker M, Ruiz-Ruiz C, Robledo G, Lopez-Rivas A: Stimulation of the mitogen-aetivated protein kinase pathway antagonizes TRAIL-induced apoptosis downstream of BID cleavage in human breast cancer MCF-7 cells. Oncogene 2002;21:4323-4327.
37. Li D, Yang B, Mehta JL: Tumor necrosis factor a enhances hypoxia-reoxygenation-mediated apoptosis in cultured human coronary artery endothelial cells: Critical role of protein kinase C. Cardiovasc Res 1999;42:805-813.
38. Prezioso JA, Wang J, Kim M, Duty L, Tweardy DJ, Gorclik E: Augmentation of TNF cytotoxicity by protein kinase C inhibitors: Role of arachidonic acid and manganese superoxide dismutase. Cytokine 1995;7:517-525.
39. Roychowdhury D, Lahn M: Antisense therapy directed to protein kinase C-alpha (Affinitak, LY900003/ISIS 3521): Potential role in breast cancer. Semin Oncol 2003;30:30-33.
40. Gamet-Payrastre L, Manenti S, Gratacap MP, Tulliez J, Cliap H, Payrastre B: Flavonoids and the inhibition of PKC and PI 3-kinase. Gen Pharmacol 1999;32:279-286.
41. Yang L, Kim HT, Munoz-Medellin D, Reddy P, Brown PH: Induction of retinoid resistance in breast cancer cells by overexpression of cJun. Cancer Res 1997;57:4652-4661.